Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia
Conditions
- Efficacy and Safety
- Heterozygous Familial Hypercholesterolemia
- PCSK9
Interventions
- BIOLOGICAL: protein convertase subtilisin/kexin type 9 inhibitor
Sponsor
Shenzhen People's Hospital
Collaborators